Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-27T19:49:05.507Z Has data issue: false hasContentIssue false
  • English
  • Français

Importance of N-terminal pro-brain natriuretic peptide in monitoring acute rheumatic carditis

Published online by Cambridge University Press:  28 October 2013

Feyza Esen ,
Mustafa Argun ,
Özge Pamukçu ,
Abdullah Ozyurt ,
Ali Baykan ,
Sadettin Sezer ,
Zeynep Baykan ,
Kazım Uzum  and
Nazmi Narin
Feyza Esen
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Mustafa Argun*
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Özge Pamukçu
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Abdullah Ozyurt
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Ali Baykan
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Sadettin Sezer
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Zeynep Baykan
Affiliation:
Department of Medical Education, Erciyes University Medical Faculty, Kayseri, Turkey
Kazım Uzum
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Nazmi Narin
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
*
Correspondence to: Dr M. Argun, Department of Pediatrics, Division of Pediatric Cardiology, Erciyes University Medical Faculty, Melikgazi 38039, Kayseri, Turkey. Tel: +90 352 2076666, ext: 25036; Fax: +90 352 4375825; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Purpose

To detect the relationship of N-terminal pro-brain natriuretic peptide levels with clinical and laboratory findings by measuring them at diagnosis, during, and after treatment in children with acute rheumatic carditis.

Method

A total of 40 children including 20 acute rheumatic carditis patients aged between 5 and 16 years 20 healthy children as controls were included in the study. Blood was drawn from patients at diagnosis and in the first week, first month and third month after treatment in order to detect pro-brain natriuretic peptide, C-reactive protein levels and erythrocyte sedimentation rates. All patients underwent echocardiography.

Results

The N-terminal pro-brain natriuretic peptide levels of children with acute rheumatic carditis were significantly higher than those of the control group at diagnosis and during treatment (p<0.05). Echocardiographic evaluation of acute rheumatic carditis patients revealed that the left atrium diameter continued to decrease during the study and that the mean left atrium diameters measured at diagnosis and in the first week were statistically higher than the mean left atrium diameters measured in the third month. There was significant correlation between left atrium diameters at diagnosis and in the first month and N-terminal pro-brain natriuretic peptide levels during the same periods in the patient group.

Conclusion

Previous studies have used N-terminal pro-brain natriuretic peptide levels as a marker of enlargement of the left atrium, whereas in this study we want to emphasise its role as a marker of inflammation. This increase was significantly correlated with enlargement in the left atrium. N-terminal pro-brain natriuretic peptide levels were found to be a valuable determinant in indicating cardiac inflammation and haemodynamics.

Keywords

Rheumatic feverN-terminal pro-brain natriuretic peptideechocardiographyleft atrium
Type
Original Articles
Information
Cardiology in the Young , Volume 25 , Issue 1 , January 2015 , pp. 110 - 114
Copyright
Copyright &#x00A9; Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Baykal, Y, Sağlam, K, Turan, M. The pathogenesis of acute rheumatic fever. Türkiye Klinikleri J Med Sci 1998; 18: 231–235.Google Scholar
2. Sutton, TM, Stewart, RA, Gerber, IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280–2287.Google Scholar
3. Golbaşı, Z, Uçar, O, Yuksel, AG, et al. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease. Eur J Heart Fail 2004; 6: 757–760.Google Scholar
4. Davutoglu, V, Celik, A, Aksoy, M, et al. Plasma N-terminal pro brain natriuretic peptide is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur J Heart Fail 2005; 7: 532–536.Google Scholar
5. Iltumur, K, Karabulut, A, Yokus, B, et al. N-terminal pro brain natriuretic peptide plasma levels correlate with severity of mitral stenosis. J Heart Valve Dis 2005; 14: 735–741.Google ScholarPubMed
6. Tani, LY. Rheumatic fever and rheumatic heart disease. In: Allen HD, Driscoll DJ, Shaddy RE, Felte TF (eds). Moss and Adams’ Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adults, 7th edn. Lippincott Williams & Wilkins, Philadelphia, 2008: 1256–1280.Google Scholar
7. Narin, N, Kütükçüler, N, Ozyürek, R, et al. Lymphosyte subset and plasma IL-1 alpha, IL-2, TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol 1995; 77: 172–176.Google Scholar
8. Olguntürk, R, Aydın, GB, Tunaoğlu, FS, et al. Rheumatic heart disease prevalence among schoolchildren in Ankara, Turkey. Turk J Pediatr 1999; 41: 201–206.Google Scholar
9. Cilliers, AM. Rheumatic fever and its management. BMJ 2006; 333: 1153–1156.Google Scholar
10. Gerber, IL, Stewart, RA, French, JK, et al. Associations between plazma natriüretic peptide levels, symptoms and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol 2003; 92: 755–758.CrossRefGoogle Scholar
11. Potocki, M, Mair, J, Weber, M, et al. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation. Am J Cardiol 2009; 104: 559–564.Google Scholar
12. Cimen, O, Oran, B, Cimen, D, et al. Release of N-terminal pro-brain natriuretic peptide in children with acute rheumatic carditis. Cardiol Young 2010; 20: 297–301.Google Scholar
13. Nir, A, Bar-Oz, B, Perles, Z, et al. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Pediatr 2004; 93: 603–607.Google Scholar
14. Tavlı, V, Sarıtas, T, Saylan, B, et al. Diagnostic value of ‘Brain natriuretic peptide’ in children with hemodynamically significant heart disease. Türkiye Klinikleri J Med Sci 2010; 30: 243–250.Google Scholar
15. Fried, I, Bar-Oz, B, Perles, Z, et al. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction. J Pediatr 2006; 149: 28–31.CrossRefGoogle ScholarPubMed